drugset
drugset / Trial / NCT03637049

Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects

NCT03637049 ↗

Phase 1 Completed 22 enrolled Liminal BioSciences Ltd. Celerion · collab
NaSingle-groupOpen-labelBasic science

Summary

This study is designed to evaluate the pharmacokinetics (PK) and safety of multiple doses of PBI-4050 combined with midazolam in healthy adult subjects.

Timeline

Start
2018-07-17
Primary completion
2018-08-09
Completion
2018-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 2 mg Oral
Subject SETOGEPRAM Small molecule 1200 mg —

Indications

No indication recorded.